Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management

Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management

Summary: Neurofilament light chain (NfL) is a long-awaited blood biomarker that can provide clinically useful information about prognosis and therapeutic efficacy in multiple sclerosis (MS). There is now substantial evidence for this biomarker to be used alongside magnetic resonance imaging (MRI) an...

Full description

Bibliographic Details
Main Authors: Mark S. Freedman, Sharmilee Gnanapavan, Ronald A. Booth, Peter A. Calabresi, Michael Khalil, Jens Kuhle, Jan Lycke, Tomas Olsson
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:EBioMedicine
Subjects:
Multiple sclerosis
Neurofilament light chain
Cerebrospinal fluid biomarkers
Serum biomarkers
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396424000057

Internet

http://www.sciencedirect.com/science/article/pii/S2352396424000057

Similar Items